Gram Stain Clinical Trials

• Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
  ClinicalTrials.gov Identifier: NCT00540371 - Enrolling by invitation
  Port Wine Stain
  
• Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks
  ClinicalTrials.gov Identifier: NCT00580944 - Enrolling by invitation
  Port Wine Stain
  
• Emergence of Gram-Negative Resistance in Blood Culture Isolates of Solid-Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00304330 - Recruiting
  Gram Negative Infection
  
• Surveillance Study - Incidence of Antibiotic Resistance in Serial Gram-Negative Bloodstream Isolates
  ClinicalTrials.gov Identifier: NCT00394784 - Recruiting
  Gram-Negative Bacterial Infections
  
• Gram Negative Bacteremia, Risk Factors for Failure of Therapy
  ClinicalTrials.gov Identifier: NCT00177957 - Recruiting
  Gram-Negative Bacterial Infections
  
• Resistance Rates and Mechanisms of Resistance to Imipenem and Meropenem at UPMC Presbyterian to Problematic Gram-Negative Organisms
  ClinicalTrials.gov Identifier: NCT00443885 - Recruiting
  Gram Negative Organism
  
• Measurement Skin TemperatureDuring Pulsed Laser Exposure
  ClinicalTrials.gov Identifier: NCT00540917 - Enrolling by invitation
  Port Wine Stain Birthmark
  
• Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform
  ClinicalTrials.gov Identifier: NCT00247299 - Active, not recruiting
  Telangiectases; Port Wine Stain
  
• Pharmacokinetic Study of Single Dose Daptomycin in Pediatric Patients with Gram Positive Infection for Which They Are Receiving Standard Antibiotics.
  ClinicalTrials.gov Identifier: NCT00136292 - Completed
  Gram positive infection
  
• Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser
  ClinicalTrials.gov Identifier: NCT00365118 - Active, not recruiting
  Port-Wine Stain
  
• Optical Clearing of the Skin in Conjunction With Laser Treatments
  ClinicalTrials.gov Identifier: NCT00580736 - Enrolling by invitation
  Port Wine Stain; Benign Vascular Lesion; Nevus of Ota; Tattoos; Scars; Acne; Hypertrichosis; Sebaceous Hyperplasia
  
• Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
  ClinicalTrials.gov Identifier: NCT00035425 - Completed
  Neutropenia; Fever; Gram-Positive Bacterial Infections; Neoplasms
  
• Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
  ClinicalTrials.gov Identifier: NCT00573729 - Enrolling by invitation
  Port Wine Stains
  
• Phase 2 Trial of TD-6424 Versus Standard Therapy for Complicated Gram Positive Infections of the Skin and Soft Tissue
  ClinicalTrials.gov Identifier: NCT00077675 - Completed
  Infections, Gram-Positive Bacterial
  
• Daptomycin for the Treatment of Infections Due to Gram-positive Bacteria
  ClinicalTrials.gov Identifier: NCT00055198 - Completed
  Gram-Positive Bacterial Infections
  
• Tigecycline for the Treatment of Subjects with Selected Serious Infections Due to Resistant Gram-Negative Organisms
  ClinicalTrials.gov Identifier: NCT00079989 - Completed
  Gram-Negative Bacterial Infections; Pneumonia; Bacteremia
  
• Antibiotic Treatment for Patients with Infections of Short Term In-dwelling Vascular Catheters Due to a Specific Bacteria (Gram Positive Bacteria)
  ClinicalTrials.gov Identifier: NCT00037050 - Completed
  Bacterial Infections; Gram-Positive Bacterial Infections; Bacteremia
  
• Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
  ClinicalTrials.gov Identifier: NCT00177814 - Recruiting
  Gram-Negative Bacterial Infections
  
• Catheter Related - Gram Positive Bloodstream Infections
  ClinicalTrials.gov Identifier: NCT00467272 - Recruiting
  Bloodstream Infection
  
• Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
  ClinicalTrials.gov Identifier: NCT00406198 - Completed
  Bacteremia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Pneumonia, Bacterial; Shock, Septic; Sepsis
  
• Optical Biopsy of Human Skin in Conjunction With Laser Treatment
  ClinicalTrials.gov Identifier: NCT00540566 - Enrolling by invitation
  Malignant Melanoma,; Merkel Cell Carcinoma,; Basal Cell Carcinoma,; Squamous Cell Carcinoma; Atypical Nevi,; Congenital Nevi; Seborrheic Keratosis,; Paget's Disease; Dermatofibroma,; Kaposi's Sarcoma; Hypervascular Congenital Malformations; Port Wine Stain; Hemangioma; Tattoos; Scleroderma; Burns; Normal Skin
  
• Polymyxin-B Protects From Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial
  ClinicalTrials.gov Identifier: NCT00490477 - Recruiting
  Gram-Negative Bacterial Infections; Sepsis
  
• Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections
  ClinicalTrials.gov Identifier: NCT00501150 - Completed
  Gram-Positive Bacterial Infections; Staphylococcal Infections
  
• Treatment of Acute Pyelonephritis with Gram Negative Strains in Infants and Children Less Than 3 Years Old
  ClinicalTrials.gov Identifier: NCT00136656 - Recruiting
  Pyelonephritis
  
• A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-Negative Sepsis in Adult
  ClinicalTrials.gov Identifier: NCT00563134 - Suspended
  Gram-Negative Bacterial Infections; Sepsis
  
• Phase 2 Trial of TD 6424 Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections
  ClinicalTrials.gov Identifier: NCT00061633 - Completed
  Infections, Gram-Positive Bacterial; Abscess; Burns; Cellulitis; Ulcer; Wound Infections
  
• Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
  ClinicalTrials.gov Identifier: NCT00414362 - Recruiting
  Urinary Tract Infection; Fluoroquinolone; Bacteremia
  
• Telavancin (TD 6424, ARBELIC™) for Treatment of Uncomplicated Staphylococcus aureus Bacteremia
  ClinicalTrials.gov Identifier: NCT00062647 - Completed
  Gram-Positive Bacterial Infections
  
• Linezolid in the Treatment of Hemodialysis Patients with Catheter-Related Gram-Positive Bloodstream Infections
  ClinicalTrials.gov Identifier: NCT00108433 - Terminated
  Bacteremia; Gram-Positive Bacterial Infections
  
• Time To Efficacy and Onset Of Action Of Linezolid
  ClinicalTrials.gov Identifier: NCT00147511 - Completed
  Gram-Positive Bacterial Infections; Skin and Connective Tissue Diseases
  
• A Study of Ceftobiprole in Patients Who Have a Fever and Have Abnormally Low Numbers of the White Blood Cells Called Neutrophils in the Blood Stream (Neutropenia).
  ClinicalTrials.gov Identifier: NCT00529282 - Not yet recruiting
  Neutropenia; Pseudomonas; Gram-Positive Bacterial Infections; Fever
  
• New Antibiotic to treat patients with community-acquired pneumonia due to a specific bacteria (S. pneumoniae pneumonia)
  ClinicalTrials.gov Identifier: NCT00035269 - Completed
  Pneumonia, Pneumococcal; Community Acquired Infections; Gram-Positive Bacterial Infections
  
• Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
  ClinicalTrials.gov Identifier: NCT00167960 - Completed
  Gram-Positive Bacterial Infections
  
• Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
  ClinicalTrials.gov Identifier: NCT00167999 - Completed
  Gram-Positive Bacterial Infections; Escherichia Coli Infections; Klebsiella Infections
  
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-negative Severe Sepsis In Adults
  ClinicalTrials.gov Identifier: NCT00089986 - Completed
  Sepsis; Septic Shock
  
• TD-1792 in Gram-Positive Complicated Skin and Skin Structure Infection
  ClinicalTrials.gov Identifier: NCT00442832 - Completed
  Complicated Skin and Skin Structure Infection
  
• Open-Label, Multiple-Dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00240747 - Terminated
  Gram-Positive Bacterial Infections
  
• A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of HSV-2 Genital Herpes In Newly Diagnosed Patients
  ClinicalTrials.gov Identifier: NCT00158860 - Completed
  genital herpes caused by HSV-2 virus